Samsung Bioepis Receives European Commission Approval for AYBINTIO® (Bevacizumab)

NEXT STORY
In Vitro Diagnostics Market to Reach USD 87.11 Billion by 2026; Increasing Prevalence of Cancer Will Enable Growth, says Fortune Business Insights
PREV STORY
Biofidelity raises $12m in Series A financing
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Samsung Bioepis Receives European Commission Approval for AYBINTIO® (Bevacizumab)

NEXT STORY
In Vitro Diagnostics Market to Reach USD 87.11 Billion by 2026; Increasing Prevalence of Cancer Will Enable Growth, says Fortune Business Insights
PREV STORY
Biofidelity raises $12m in Series A financing
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Germain Dermatology Adds Image-Guided Superficial Radiotherapy with the SRT-100 Vision™ for Treating Basal and Squamous Cell Carcinoma in Charleston, SC

author_avatar
NASDAQ Market News

Lyra Therapeutics Announces Positive Topline Results of Pharmacokinetic Study of LYR-210 in Patients with Chronic Rhinosinusitis

author_avatar
NASDAQ Market News

Neuronetics® Celebrates 100,000 Treatment Milestone for Southern California TMS Center

author_avatar
NASDAQ Market News